The Latest Analyst Ratings for Pfizer
Portfolio Pulse from Benzinga Insights
In the last quarter, Pfizer (NYSE:PFE) has received various analyst ratings, with the majority being somewhat bullish or indifferent. Over the past 3 months, 11 analysts have offered 12-month price targets for Pfizer, with an average price target of $53.09, an increase of 6.44% from the previous average price target of $49.88.
August 22, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pfizer has received a mix of analyst ratings in the last quarter, with the majority being somewhat bullish or indifferent. The average price target has increased by 6.44% to $53.09.
The increase in Pfizer's average price target and the majority of somewhat bullish or indifferent ratings suggest a positive outlook for the company's stock in the short term. This could potentially lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100